BioMarin Pharmaceutical
BMRN
#1897
Rank
$10.33 B
Marketcap
$53.82
Share price
-0.90%
Change (1 day)
-19.08%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: $10.33 Billion USD

As of December 2025 BioMarin Pharmaceutical has a market cap of $10.33 Billion USD. This makes BioMarin Pharmaceutical the world's 1897th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025$10.33 B-18.89%
2024$12.74 B-29.81%
2023$18.16 B-5.57%
2022$19.23 B18.58%
2021$16.22 B1.9%
2020$15.91 B4.69%
2019$15.20 B0.18%
2018$15.17 B-3.08%
2017$15.66 B9.92%
2016$14.24 B-15.8%
2015$16.92 B25.55%
2014$13.47 B33.54%
2013$10.09 B63.05%
2012$6.18 B57.63%
2011$3.92 B31.8%
2010$2.97 B56.88%
2009$1.89 B6.88%
2008$1.77 B-48.31%
2007$3.43 B128.67%
2006$1.50 B87.69%
2005$0.80 B94.33%
2004$0.41 B-17.21%
2003$0.49 B31.3%
2002$0.37 B-46.16%
2001$0.70 B96.89%
2000$0.35 B-12.6%
1999$0.40 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of BioMarin Pharmaceutical was reported to be:

$10.33 Billion USD
by Nasdaq info icon info icon
$10.33 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
$3.52 B-65.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$0.17 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.89 B-91.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$119.36 B 1,054.41%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
$3.06 B-70.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
$2.83 B-72.56%๐Ÿ‡บ๐Ÿ‡ธ USA